A
Anavex Life Sciences Corp.
AVXL · NASDAQ · Healthcare · 298M
Price · close
$3.24
+3.51% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.9×
Enterprise value / EBITDAEV/EBITDA
-3.7×
Free cash flow yieldFCF yield
-14.1%
Return on equityROE
-48.9%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
2.2×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.